EUVIMEDEUVIMED entdecken
Crossref

K V channel antagonism blunts vasodilatation in skeletal muscle of humans

Ysabella I Ruiz-Pick iD, Rauchelle E Richey iD, Tyson C Garfield, Asim Kichloo, Albert H Olivencia-Yurvati, Gregory M Dick iD, Steven A Romero iD

The Journal of Physiology · 2025

DOI: 10.1113/jp289720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2025. Verfasst von Ysabella I Ruiz-Pick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Human Vascular Physiology Laboratory, Department of Physiology and Anatomy, UNT Health Fort Worth, Fort Worth, TX, USA. Hauptthemen laut MEDLINE: Vasodilation, Potassium Channel Blockers, 4-Aminopyridine, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: American Heart Association, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Voltage‐dependent potassium (K V ) channels play a pivotal role in regulating vascular tone via negative feedback control of membrane potential. Despite substantial evidence in animal models, many aspects of their regulation are not fully understood in humans, particularly within the skeletal muscle microcirculation. Therefore, we tested the hypothesis that K V channel antagonism would attenuate pharmacologically induced vasodilatation in skeletal muscle of humans. We utilised microdialysis to directly measure the local hyperaemic response to methacholine (55 m m ; endothelium‐dependent) and sodium nitroprusside (42 m m ; endothelium‐independent) in the vastus lateralis muscle of 17 healthy adults (seven women). At separate sites, the K V channel antagonist, 4‐aminopyridine (26.6 m m ), was co‐perfused with each vasodilator agent. Local skeletal muscle blood flow was assessed using the ethanol washout technique. Baseline blood flow did not differ between probes perfused with 0.9% saline and those perfused with 4‐aminopyridine ( P = 0.375). However, the hyperaemic response to methacholine (Δ 28 ± 12 mL min −1 100 g −1 ) was abolished when co‐perfused with 4‐aminopyridine (Δ 3 ± 9 mL min −1 100 g −1 , P < 0.001). Likewise, the hyperaemic response to sodium nitroprusside (Δ 59 ± 27 mL min −1 100 g −1 ) was reduced when co‐perfused with 4‐aminopyridine (Δ 14 ± 10 mL min −1 100 g −1 , P < 0.001). These data suggest that K V channels play a major role in pharmacologically induced vasodilatation in skeletal muscle of humans and serve as major downstream effectors in the nitric oxide‐cyclic guanosine monophosphate‐protein kinase G (i.e. NO/cGMP/PKG) signalling pathway. image Key points Voltage‐dependent potassium (K V ) channels play a pivotal role in regulating vascular tone via negative feedback control of membrane potential. Despite substantial evidence in animal models, many aspects of their regulation are not fully understood in humans, particularly within the skeletal muscle microcirculation. We tested the hypothesis that K V channel antagonism would attenuate the vasodilatation induced by methacholine and sodium nitroprusside in the vastus lateralis muscle of young healthy humans. Utilising microdialysis, we found that K V channel antagonism, via perfusion of 4‐aminopyridine, blunted the hyperaemic response to methacholine and sodium nitroprusside in the vastus lateralis muscle. We identified a critical role for K V channels in the vasodilatation induced by methacholine and sodium nitroprusside in skeletal muscle of humans. Because both pharmacological agents induce vasodilatation via nitric oxide‐cyclic guanosine monophosphate‐protein kinase G (i.e. NO/cGMP/PKG) signalling, these findings suggest that K V channels are major downstream effectors of this pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VasodilationPotassium Channel Blockers4-AminopyridineMuscle, SkeletalPotassium Channels, Voltage-GatedHumansMaleFemaleAdultYoung AdultNitroprussideVasodilator AgentsMethacholine Chloride

Stichwörter der Autor:innen

methacholinemicrodialysissodium nitroprussidevoltage‐dependent K+ channels

Substanzen

Potassium Channel Blockers4-AminopyridinePotassium Channels, Voltage-GatedNitroprussideVasodilator AgentsMethacholine Chloride

Autor:innen und Institutionen

  • Human Vascular Physiology Laboratory, Department of Physiology and Anatomy, UNT Health Fort Worth, Fort Worth, TX, USA.
  • Department of Human Physiology, University of Oregon, Eugene, OR, USA.
  • Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Medicine, UNT Health Fort Worth, Fort Worth, TX, USA.
  • Department of Surgery, UNT Health Fort Worth, Fort Worth, TX, USA.

ORCID-Profile: Ysabella I Ruiz-Pick, Rauchelle E Richey, Gregory M Dick, Steven A Romero

Förderung

  • American Heart Association
  • National Institute on Aging

Zitieren

APA

Ruiz-Pick, Y. I., Richey, R. E., Garfield, T. C., Kichloo, A., Olivencia-Yurvati, A. H., Dick, G. M., & Romero, S. A. (2025). K V channel antagonism blunts vasodilatation in skeletal muscle of humans. The Journal of Physiology. https://doi.org/10.1113/jp289720

Vancouver

Ruiz-Pick YI, Richey RE, Garfield TC, Kichloo A, Olivencia-Yurvati AH, Dick GM, et al. K V channel antagonism blunts vasodilatation in skeletal muscle of humans. The Journal of Physiology. 2025. doi:10.1113/jp289720

BibTeX
@article{RuizPick2025,
  author = {Ruiz-Pick, Ysabella I and Richey, Rauchelle E and Garfield, Tyson C and Kichloo, Asim and Olivencia-Yurvati, Albert H and Dick, Gregory M and Romero, Steven A},
  title = {K V channel antagonism blunts vasodilatation in skeletal muscle of humans},
  journal = {The Journal of Physiology},
  year = {2025},
  doi = {10.1113/jp289720}
}
Kostenlos starten →